When to initiate ACEI/ARB therapy in patients with type 1 and 2 diabetes
✍ Scribed by Kevin V. Lemley
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 245 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Objective: Diabetic patients (dp) refer increased hunger sensation (hs) when hyperglycemic but not yet ketogenic. as hs shows a within-day (ultradian cyclicity) and intra-day (circadian cyclicity) repetitivity, its recursive pattern was investigated in patients with type 1 and type 2 diabetes me
## Abstract ## Background Type 1 diabetes results from a T‐cell mediated autoimmune destruction of insulin‐producing pancreatic beta‐cells. The 60‐kDa heat‐shock protein (hsp60) is one of the known target self‐antigens. An immunogenic peptide from hsp60, p277, arrested beta‐cell destruction and ma